Literature DB >> 20554798

Age-dependent differences in the pathogenesis of bovine respiratory syncytial virus infections related to the development of natural immunocompetence.

Adriaan F G Antonis1, Marina C de Jong, Wim H M van der Poel, Robbert G van der Most, Norbert Stockhofe-Zurwieden, Tjeerd Kimman, Remco S Schrijver.   

Abstract

The severity of respiratory syncytial virus (RSV) infections appears to differ with age in both humans and bovines. A primary RSV infection in naïve infants and in young calves runs a more severe course when they are 1-6 months old than in their first month of life. The relative lack of clinical signs in the first month of age may be due to high levels of maternally derived neutralizing antibodies or low exposure to infectious virus. This study examined whether age-dependent differences in the pathogenesis of bovine RSV (bRSV) between neonatal and young calves may be due to differences in age-dependent immunocompetence. To study the effect of age and immune parameters on bRSV disease in neonatal and young calves, neonatal (1-day-old) calves without maternally derived antibodies were infected experimentally with bRSV and the severity of disease and immune responses were evaluated in comparison with disease in similar 6-week-old infected calves. Neonatal calves had more extensive virus replication and lung consolidation, but lower pro-inflammatory [in particular tumour necrosis factor alpha (TNF-α)] responses, specific humoral immune responses, lung neutrophilic infiltration and clinical signs of disease than 6-week-old calves. The lack of correlation between virus replication and clinical signs suggests an important role of pro-inflammatory cytokines, in particular TNF-α, in the disease. The capacity to produce pro-inflammatory TNF-α appeared to increase with age, and may explain the age-dependent differences in RSV pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554798     DOI: 10.1099/vir.0.020842-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Detection of antibodies and risk factors for infection with bovine respiratory syncytial virus and parainfluenza virus 3 in dual-purpose farms in Colima, Mexico.

Authors:  Daniel Figueroa-Chávez; José C Segura-Correa; Luís Jorge García-Márquez; Alfonso Pescador-Rubio; Arturo Gerardo Valdivia-Flores
Journal:  Trop Anim Health Prod       Date:  2012-01-21       Impact factor: 1.559

Review 2.  Animal models of human respiratory syncytial virus disease.

Authors:  Reinout A Bem; Joseph B Domachowske; Helene F Rosenberg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-13       Impact factor: 5.464

3.  Infant baboons infected with respiratory syncytial virus develop clinical and pathological changes that parallel those of human infants.

Authors:  James F Papin; Roman F Wolf; Stanley D Kosanke; Justin D Jenkins; Sara N Moore; Michael P Anderson; Robert C Welliver
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-02-15       Impact factor: 5.464

4.  Alveolar macrophage functions during the transition phase to active immunity in calves1.

Authors:  Heloisa G Bertagnon; Camila F Batista; Kamila R Santos; Renata C Gomes; Jessyca B Bellinazzi; Alice Maria M P Della Libera
Journal:  J Anim Sci       Date:  2018-09-07       Impact factor: 3.159

5.  A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.

Authors:  Fabián E Díaz; Mariana Guerra-Maupome; Paiton O McDonald; Daniela Rivera-Pérez; Alexis M Kalergis; Jodi L McGill
Journal:  Front Immunol       Date:  2021-04-26       Impact factor: 7.561

6.  Inflammatory responses to acute pneumovirus infection in neonatal mice.

Authors:  Cynthia A Bonville; Catherine Ptaschinski; Caroline M Percopo; Helene F Rosenberg; Joseph B Domachowske
Journal:  Virol J       Date:  2010-11-15       Impact factor: 4.099

7.  A bovine respiratory syncytial virus model with high clinical expression in calves with specific passive immunity.

Authors:  Krister Blodörn; Sara Hägglund; Dolores Gavier-Widen; Jean-François Eléouët; Sabine Riffault; John Pringle; Geraldine Taylor; Jean François Valarcher
Journal:  BMC Vet Res       Date:  2015-03-25       Impact factor: 2.741

Review 8.  Animal models of respiratory syncytial virus infection.

Authors:  Geraldine Taylor
Journal:  Vaccine       Date:  2016-11-29       Impact factor: 3.641

Review 9.  Current concepts and progress in RSV vaccine development.

Authors:  Aleks K Guvenel; Christopher Chiu; Peter Jm Openshaw
Journal:  Expert Rev Vaccines       Date:  2014-01-09       Impact factor: 5.683

10.  Human respiratory syncytial virus memphis 37 causes acute respiratory disease in perinatal lamb lung.

Authors:  Rachel J Derscheid; Albert van Geelen; Jack M Gallup; Thomas Kienzle; Daniel A Shelly; Tomas Cihlar; Robert R King; Mark R Ackermann
Journal:  Biores Open Access       Date:  2014-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.